6Portoles J, Lopez-Gomez JM, Aljama P. Anemia management and treatment response in patients on hemodialysis: the MAR study[J]. J Nephrol,2006,19(3) :352-360.
7Li H, Wang SX. Intravenous iron sucrose in peritoneal dialysis patients with renal anemia[J]. Petit Dial Int, 2008, 28(2): 149-154.
8Matthias L, Josef K, Agnes P, et al. Anemia and iron defi- ciencies among Long-Term renal transplant reeipients[J]. J Am Soe Nephrol, 2002, 13(3):794-797.
9De AF, Novembrino C, Lonati S, et al. Two different modali- ties of iron glueonate i. v. administration: effects on iron, oxi-dative and inflammatory status in peritoneal dialysis patients[J]. Nephrol Dial Transplant, 2007,22(6):1709-1713.
10Cooke M, Lamptugh A, Naudeer S, et al. Efficacy and tolera- bility of accelerated-dose low molecular-weight iron dextran (Cosmofer)in patients with chronic kidney disease [J]. Am J Nephrol,2012,35(1):69-74.
